Our results showed that the METTL3 genome sequence was hypomethylated in ovarian tumor samples and cells, indicating that a high level of METTL3 correlated with poor prognosis of patients with ovarian cancer, and suggesting that METTL3 might participate in ovarian cancer development. Here, METTL3 is linked to ovarian carcinoma.